NOV
37
-2
COF
60
-4
AVY
74
2
XYL
43
-4
RHI
43
15
HAL
41
11
LYB
32
2
AEP
56
-2
GME
59
-6
PDCO
57
2
TRV
43
-3
HBAN
33
2
MAT
50
18
BSX
70
2
CNP
65
-3
ILMN
36
10
CB
58
-2
INTU
69
4
O
37
-2
MDLZ
36
4
NOV
37
-2
COF
60
-4
AVY
74
2
XYL
43
-4
RHI
43
15
HAL
41
11
LYB
32
2
AEP
56
-2
GME
59
-6
PDCO
57
2
TRV
43
-3
HBAN
33
2
MAT
50
18
BSX
70
2
CNP
65
-3
ILMN
36
10
CB
58
-2
INTU
69
4
O
37
-2
MDLZ
36
4
Financhill
Back

Driven Brands Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
53

DRVN
Driven Brands Holdings

Last Price:
12.01
Seasonality Move:
-7.62%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
53
Driven Brands Holdings (DRVN) is a Buy

Is Driven Brands Holdings a Buy, Sell or Hold?

  • The current Driven Brands Holdings [DRVN] share price is $12.02. The Score for DRVN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • DRVN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DRVN Stock Price Chart

What is Driven Brands Holdings's stock price today?

  • The Driven Brands Holdings share price today is $12.02
    The current trend is relatively stagnant and DRVN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 57.39 Buy
Chaikin Money Flow: 1697881 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11 - 11.58) Buy
Bollinger Bands (100): (11.71 - 14.85) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

DRVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.47 Buy
20-day SMA: 11.36 Buy
50-day SMA: 12.3 Sell
200-day SMA: 13.03 Sell
8-day EMA: 11.54 Buy
20-day EMA: 11.5 Buy
50-day EMA: 12.13 Sell
200-day EMA: 14.61 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Driven Brands Holdings Earnings Growth & DRVN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.12 per share, an increase this year of $0.04 per share, and an increase next year of $0.31 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Driven Brands Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):